BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 21945668)

  • 1. Conformational change of adenine nucleotide translocase-1 mediates cisplatin resistance induced by EBV-LMP1.
    Zhao L; Deng X; Li Y; Hu J; Xie L; Shi F; Tang M; Bode AM; Zhang X; Liao W; Cao Y
    EMBO Mol Med; 2021 Dec; 13(12):e14072. PubMed ID: 34755470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review.
    de Almeida NAA; Ribeiro CRA; Raposo JV; de Paula VS
    Viruses; 2021 May; 13(5):. PubMed ID: 34063186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.
    Lin YT; Chao CC
    Oncotarget; 2015 Nov; 6(36):38999-9017. PubMed ID: 26517516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
    Liu YC; Chang PY; Chao CC
    Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-ethylmaleimide-sensitive factor attachment protein α (αSNAP) regulates matrix adhesion and integrin processing in human epithelial cells.
    Naydenov NG; Feygin A; Wang L; Ivanov AI
    J Biol Chem; 2014 Jan; 289(4):2424-39. PubMed ID: 24311785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double plant homeodomain (PHD) finger proteins DPF3a and -3b are required as transcriptional co-activators in SWI/SNF complex-dependent activation of NF-κB RelA/p50 heterodimer.
    Ishizaka A; Mizutani T; Kobayashi K; Tando T; Sakurai K; Fujiwara T; Iba H
    J Biol Chem; 2012 Apr; 287(15):11924-33. PubMed ID: 22334708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein.
    Farrell PJ
    Trends Microbiol; 1998 May; 6(5):175-7; discussion 177-8. PubMed ID: 9614338
    [No Abstract]   [Full Text] [Related]  

  • 8. [Signal transduction pathways and esophageal carcinoma].
    Li SS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):366-9. PubMed ID: 17822619
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ; Pathmanathan R; Raab-Traub N
    Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
    Liao W; Tang M; Yin L
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):199-201. PubMed ID: 11783085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
    Chang PY; Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression.
    Wu ZZ; Chow KP; Kuo TC; Chang YS; Chao CC
    Biochem Pharmacol; 2011 Dec; 82(12):1860-72. PubMed ID: 21945668
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.